Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
Diterpenoid epoxide found in Tripterygium.
Polypeptide; peptidoglycan inhibitor.
c-MET and Ron inhibitor.
Antioxidant, vitamin E derivative found in vege...
mAChR agonist, selective for M2.
Polyene macrolide; ergosterol inhibitor.
Selective inhibitor of PI3Kβ and PI3Kδ.
GHB agonist, D2/3 antagonist.
EGFR inhibitor.
EZH2 HMT inhibitor.
Phenothiazine, FIASMA; D1/2/3/4, 5-HT1/2, M1/2 ...
α4β2 nAChR desensitizer, delayed-rectifier vo...
Endogenous peptide fragment, involved in vasoco...
Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...
Polycationic aminoglycoside; protein translatio...
Indoleamine-2,3-dioxygenase inhibitor.
TRPC5, NS4B, histamine H1 inhibitor.
Induces ER degradation.
Aromatic acridine derivative, DNA intercalator....
HDAC inhibitor, mammalian RNA splicing modulato...